Skip to main content
. 2022 Nov 10;52:19–28. doi: 10.1016/j.jare.2022.11.003

Fig. 3.

Fig. 3

GLUT9, URAT1, ABCG2, Nrf2, NLRP3, TLR4, MyD88, NF-κB, MMP-2, MMP-9, and TIMP-1 levels in hyperuricemic rats treated for 6 weeks with SFN. GLUT9, URAT1, and ABCG2 (A) and Nrf2, NLRP3, TLR4, MyD88, NF-κB, MMP-2, MMP-9, and TIMP-1 (B) (n = 5). The samples derived from the same experiment and that blots were processed in parallel.